HIV in Scotland — The Challenge Ahead

Goldberg D Davis B Allardice G McMenamin J Codere G. Monitoring the spread of HIV and AIDS in Scotland 1983–1994. Scot Med J 1996: 41(5): 131–38.

Robertson JR Bucknall ABV Welsby PD Inglis JM Peutherer JF Brettle RP Roberts JK . Epidemic of AIDS related virus (HTLV iii/LAV) infection among intravenous drug users. Br Med J 1986: 292: 527–29.

Surveillance Report HIV & AIDS. HIV Infection and AIDS: Quarterly report to 30 June 1998. ANSWER (AIDS News Supplement to the Weekly Report) 1998: 32 (98/28): 148–155.

Delta Co-ordinating Committee. Delta: A randomised double blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. The Lancet 1996; 348: 283–291.

Hammer SM Katzensteni DA Hughes MD A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200–500 per cubic millimetre. New Eng J Med 1996: 335: 1081–90.

Stazewski S Hill AM Bartlett J , Reductions in HIV-1 disease progression for ZDV/3TC relative to control treatments: A meta: Analysis of controlled trials. AIDS 1997: 11: 477–83.

CAESAR Co-ordinating Committee: Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: The CAESAR trial. The Lancet 1997: 349: 1413–1421.

Allardice GM McMenarnin JJ Parpia T. The recent impact of antiretroviral combination therapy on CD4 count in HIV infected persons: As shown by routine HIV surveillance in Scotland. Int J STD and AIDS (in press).

AIDS and severe HIV-related disease in Scotland – Predictions to the end of 1999. A report by a working group convened by the Chief Medical Officer for Scotland. ANSWER (AIDS News Supplement to the Weekly Report); 1995 AM-18 – WR 95/52.

Brettle RP Wilson A Povey S Morris S Morgan R Leen CLS Hutchinson S Lewis S Gore S. Combination therapy for HIV: The effect on inpatient activity, morbidity and mortality of a cohort of patients. Int J STD and AIDS 1998: 9: 80–87.

Mouton Y Alfandari S Valette M . Impact of protease inhibitors on AIDS-defining events and hospitalisations in 10 French AIDS reference centres. AIDS 1997: 11: F101–F105.

Brodt HR Kamps BS Gute P Knupp B Staszewski S Helm EB . Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 1997: 11: 1731–38.

Eggar M Hirschel B Francioli P . Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: Prospective multicentre study. Br Med J 1997: 315: 1194–99.

Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD and the HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New Eng J Med 1998: 338(13): 853–860.

Hirschel B Francioli P. Progress and problems in the fight against AIDS. New Eng J Med 1998: 338(13): 906–909.

Flexner C. HIV-Protease Inhibitors. New Eng J Med 1998: 338(18): 1281–92.

Sherer R. Adherence and antiretroviral therapy in injection drug users. JAMA 1998: 280(6): 567–568.

Celentano DD Vlahov D Cohn S Shadle VM Moore RD . Self-reported antiretroviral therapy in injection drug users. JAMA 1998: 280: 544–46.

Montaner J S G Reiss P Cooper D For the INCAS Study Group. A randomized, double-blind trial comparing combinations of nevirapine, didanosine and zidovudine for HIV-infected patients: The INCAS Trial. JAMA 1998: 279: 930–37.

AIDS and HIV infection in the United Kingdom: monthly report. Communicable Disease Report 1998:8(30).

Richman DD , How drug resistance arises. Scientific American July 1998.

Wainberg MA Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA 1998: 279(24): 1977–83.

Cohen OJ Fauci AS . HIV/AIDS in 1998 – Gaining the Upper Hand? JAMA 1998:280(1): 87–88.

Grant RM Abrams DI . Not all is dead in HIV-I gravevard. The Lancet 1998; 351: 308–309.

BHIVA Guidelines Co-ordinating Committee: British HIV Association guidelines for anti-retroviral treatment of HIV seropositive individuals. The Lancet 1997:349: 1086–1092.

Carpenter CJ Fischl MA Hammer SM , For the International AIDS Society USA: Anti-retroviral therapy for HIV Infection in 1997: Updated recommendations of the International AIDS Society-USA Panel. JAMA 1997: 277: 1962–69.

Carpenter CJ Fischl MA Hammer SM , For the International AIDS Society USA: Anti-retroviral therapy for HIV infection in 1998: Updated recommendations of the International AIDS Society-USA Panel. JAMA 1998: 280: 78–86.

Scottish HIV and AIDS Group (SHIVAG): Draft Scottish HIV Treatment Protocol 1998. Convened by the Scottish Office.

Tusiana T Katlama C Calvez V Muhand H Antran B. Long-lasting recovery in CD4 T-cell function and viral load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998: 351: 1682–86.

Guidelines on post-exposure prophylaxis for health care workers occupationally exposed to HIV. ANSWER (AIDS News Supplement to the Weekly Report) 1997:5(97/35): 1–4.

Hawkins P Easterbrook D Boag F Pearce A Vaile H Richardson C. Post-exposure prophylaxis for occupational and sexual exposures to HIV: Experience in a London hospital. 12th International Conference on AIDS, Geneva July 1998; (abstract no. 33176).

Rernien RH Wagner G Carballo-Dieguez Dolezal C. Who may be engaging in highrisk sex due to medical treatment advances? AIDS 1998:12(12): 1560–61.

Baltimore D Heilman C. HIV Vaccines: Prospects and Challenges. Scientific American July 1998.

Surveillance Report HIV and AIDS. Quarterly report to 31st December 1997.ANSWER (AIDS News Supplement to the Weekly Report) 1998: 32 (98/07): 34–43.

Goldberg D Allardice G McMenarnin J Codere G Raeside F Burns G Davis B. On behalf of the HIV/AIDS surveillance collaborators throughout Scotland. Monitoring the spread of HIV and AIDS in Scotland 1983–1996. ANSWER (AIDS News Supplement to the Weekly Report) 1997; AM-32.

Hart G Flowers P. A survey of gay mens sexual behaviour in Glasgow. Report for the Greater Glasgow Health Board 1998.

Cohen MS . Sexually transmitted diseases enhance HIV transmission: No longer a hypothesis. The Lancet 1998: 351 (Suppl. 111): 5–7

Goldberg D Scott G Weir M Cameron S Peutherer J McMillan A Leadbetter G Scoular A Codere G Allardice G. HIV infection among homosexual/bisexual males attending genito-urinary clinics in Scotland. Sexually Transmissible Infections 1998: 74: 185–88.

Frankis J Flowers P Hart G. The Gay Men's Task Force: Preliminary Process Evaluation. Report for the Greater Glasgow Health Board 1998.

Des Jarlais D Hagan H Friedman SR Friedman P Goldberg DJ Frischer M . Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA 1995: 274(15): 1226–31.

Frischer M Elliott L Taylor A Goldberg D Green ST Gruer L , Do needle exchanges help to control the spread of HIV among injecting drug users? AIDS 1993:7: 1677–78.

Brettle RP . HIV and harm reduction for injection drug users. AIDS 1991: 5: 125–136 (Editorial Review).

Frischer M Bloor M Green S Goldberg DJ McKeganey N Covell R Reduction in needle sharing among community wide samples of injecting drug users. Int J STD and AIDS 1992: 3: 288–290.

Information and Statistics Division, National Health Seivice in Scotland. Scottish Health Statistics 1997

Goldberg D, Cameron S, McMenarnin J. Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high. Communicable Disease and Public Health; Vol 1, No 2: 95–97.

Gore S Bird G. Drugs in British prisons. Br Med J 1998: 316: 1256–57.

Surveillance Report HIV & AIDS. HIV Infection and AIDS: Quarterly report to 31 March 1998. ANSWER (AIDS News Supplement to the Weekly Report) 1998: 32 (98/16): 86–93.

Pakianathan M Scott G McMillan A. Second generation heterosexual transmission of HIV-1 infection from women infected in the United Kingdom. Sexually Trasmitted Infections 1998: 74–77

Report on the global HIV/AIDS epidemic June 1998. UNAIDS/WHO Joint United National Programme on HIV/AIDS. World Health Organisation 1998.

Heterosexually acquired HIV infection in Doncaster. Communicable Disease Report 1998:8: (31).

1997 Health in Scotland: Scottish Office Department of Health.

Nicoll A McGarrigle C Brady A R Ades A E Tookey P Duong T Epidemiology and detection of HIV-1 among pregnant women in the United Kingdom: Results from national surveillance 1988–96. Br Med J 1998: 316: 253–58.

Connor E M Sperling R S Gelber R Kiselev P Scott G O'Sullivan M J Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994: 331: 1173–80.

Reducing mother to child transmission of HIV infection in the United Kingdom. Executive Summary and Recommendations of an Intercollegiate Working Party for Enhancing Voluntary Confidential HIV Testing in Pregnancy. April 1998.

Simpson WM Johnstone FD Boyd FM Goldberg DJ Hart GJ Prescott RJ . Uptake and acceptability of antenatal HIV testing: Randomised controlled trial of different methods of offering the test. Br Med J 1998; 316: 262–67.

Scott G Goldberg D Weir M Cameron S Peutherer J. Follett E HIV prevalence among heterosexuals attending genito-urinary clinics in Scotland — The African connection. Br Med J 1997: 315: 1281–82.